Biomarin Pharmaceutical Inc at JPMorgan Healthcare Conference Transcript
All right. Good morning. Good morning, and Happy New Year, everyone. My name is Cory Kasimov. I'm the Senior Large-Cap Biotech analyst at JPMorgan. It's hard to believe we're back here already, but let me add my welcome to the 38th Annual Health Care Conference. With different biotech company kicking things off for us for the first time in a long time, and it's my pleasure to introduce BioMarin and the company's Chairman and CEO, J.J. Bienaimé. And please note that following J.J.'s presentation, there's a breakout just across the hall in the Georgian room. So with that, turn it over to J.J.
©,-&
Thank you, Cory. Good morning, everybody. Bright and early here. This is the earliest time I ever presented at JPMorgan, but that's fine. So we're very excited about being here today.
As usual, this presentation will contain forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
